Hims & Hers Health Shares Down 7% Premarket; US FDA Removes Lilly's Weight-Loss Drug From Shortage List
Hims & HersHealth股價盤前下跌7%;美國FDA將Lilly的減肥藥從短缺名單中移除
Hims & Hers Health Shares Down 7% Premarket; US FDA Removes Lilly's Weight-Loss Drug From Shortage List
Hims & HersHealth股價盤前下跌7%;美國FDA將Lilly的減肥藥從短缺名單中移除
使用瀏覽器的分享功能,分享給你的好友吧